Laboratory Services
Coagulation Factor XI Activity Assay, Plasma
Print this pageUpdated Test Information:
Test Description |
Coagulation Factor XI Activity Assay, Plasma
|
|
---|---|---|
Synonym(s) |
Factor 11, UOW1218 |
|
Test ID |
F11
|
|
General Information |
Factor XI (11) activity is a PTT-based factor assay used for diagnosing deficiency of coagulation factor XI. A relatively high incidence of congenital factor XI deficiency (Hemophilia C) occurs among individuals of Ashkenazi Jewish descent. Emicizumab (Hemlibra) will affect all PTT-based assays and will overestimate the factor concentrations. |
|
Container Type |
3 mL or 5 mL Light Blue Citrate Tube |
|
Specimen Type |
Blood |
|
Specimen Requirements |
Entire Specimen |
|
Specimen Collection / Processing Instructions |
MUST PROCESS WITH 4 HOURS OF COLLECTION |
|
Minimum Sample Volume |
1 mL |
|
Limitations |
Clinical assay interference and limitations: Patients on bivalirudin (Angiomax), dabigatran (Pradaxa), argatroban (Novastan), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa) may show prolonged clotting times. This may cause an under- estimation of the factor concentrations. Emicizumab (Hemlibra) will affect all PTT-based assays and will overestimate the factor concentrations. |
|
Department (code) |
Coagulation (COAG) |
|
Methodology |
Stago STA Clottable Factor assay |
|
Estimated TAT |
By end of next business day |
|
Testing Schedule |
Monday - Friday |
|
CPT Code(s) |
85270 |
|
Reference Range |
Units: % Female Male Age Range Age Range 0-29d 23-150 0-29d 23-150 1m-2m 27-150 1m-2m 27-150 3m-5m 41-150 3m-5m 41-150 6m-11m 38-150 6m-11m 38-150 1y- 50-150 1y- 50-150 |
|
STAT Orderable (Y/N) |
Yes |
|
Performing Lab |
UW |
|
LOINC Code(s) | ||
Collection File | View/Download File |